Publications by authors named "Jas Bindra"

Claim this Profile
C
Cost-per-response of Acthar Gel versus standard of care for the treatment of noninfectious keratitis: a United States healthcare perspective.
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary Panaccio

J Comp Eff Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Diagnosis and Timely Terlipressin in Hepatorenal Syndrome Improves Projected Outcomes and Lowers Cost.
Juan F Gallegos-Orozco, Jacqueline G O'Leary, Kapuluru Gautham Reddy, Jas Bindra, Ishveen Chopra

Clinicoecon Outcomes Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost per Response of Acthar® Gel vs Standard of Care for the Treatment of Proteinuria in Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy Among Adults from the US Healthcare Perspective.
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary P Panaccio

J Health Econ Outcomes Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Insights on Satisfaction and Experience with Acthar Gel via SelfJect (RISE™): A Cross-Sectional Patient Survey.
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary Panaccio

Adv Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records.
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary Prince Panaccio

Ther Clin Risk Manag· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.
Xingyue Huang, Jas Bindra, Ishveen Chopra, John Niewoehner, George J Wan

Adv Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis.
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary Panaccio

Clinicoecon Outcomes Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus.
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary Panaccio

Adv Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis.
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary P Panaccio

J Health Econ Outcomes Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis.
Samuel F Hunter, Jas Bindra, Ishveen Chopra, John Niewoehner, Mary P Panaccio

Clinicoecon Outcomes Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis.
Jas Bindra, Ishveen Chopra, John Niewoehner, Mary Panaccio, George J Wan

Clinicoecon Outcomes Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis